These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8759053)

  • 1. Tissue repair in the iris in experimental autoimmune uveoretinitis.
    Wang J; Essner E; Shichi H
    Exp Mol Pathol; 1995 Aug; 63(1):41-51. PubMed ID: 8759053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural and immunocytochemical studies of smooth muscle cells in iris arterioles of rats with experimental autoimmune uveoretinitis.
    Wang J; Essner E; Shichi H
    Exp Mol Pathol; 1994 Dec; 61(3):153-63. PubMed ID: 7601268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
    Butler TL; McMenamin PG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
    Greenwood J; Howes R; Lightman S
    Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural and immunocytochemical studies of iris vessels in rats with experimental autoimmune uveoretinitis.
    Wang J; Lin WL; Essner E; Shichi H; Yelian FD
    Curr Eye Res; 1994 Oct; 13(10):747-54. PubMed ID: 7842725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis.
    de Vos AF; Dick AD; Klooster J; Broersma L; McMenamin PG; Kijlstra A
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3001-10. PubMed ID: 10967057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of S-antigen-induced experimental autoimmune uveoretinitis in Lewis rats by oral administration with CGS-13080, a thromboxane synthetase inhibitor.
    Li Q; Lopez JS; Caspi RR; Roberge FG; Nussenblatt RB; Kador PF; Chan CC
    Exp Eye Res; 1993 Nov; 57(5):601-8. PubMed ID: 8282047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
    Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
    Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciliary body in experimental autoimmune uveitis: tissue repair and immunoreactivity of extracellular matrix substances.
    Peng B; Shichi H
    Curr Eye Res; 1992 Nov; 11(11):1087-97. PubMed ID: 1483338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
    McPherson SW; Roberts JP; Gregerson DS
    Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
    Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased immunoreactivity of collagen types I, III and V, fibronectin and TGF-beta in retinal vessels of rats with experimental autoimmune uveoretinitis.
    Mahalak SM; Lin WL; Essner E; Shichi H
    Curr Eye Res; 1991 Nov; 10(11):1059-63. PubMed ID: 1782804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular localisation and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis.
    McMenamin PG; Crewe JM
    Exp Eye Res; 1997 Aug; 65(2):157-64. PubMed ID: 9268584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal leukocyte behavior in experimental autoimmune uveoretinitis of rats.
    Hamada M; Ogura Y; Miyamoto K; Nishiwaki H; Hiroshiba N; Honda Y
    Exp Eye Res; 1997 Sep; 65(3):445-50. PubMed ID: 9299181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial oxidative DNA damage in experimental autoimmune uveitis.
    Khurana RN; Parikh JG; Saraswathy S; Wu GS; Rao NA
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3299-304. PubMed ID: 18450595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of polymorphonuclear leukocytes in an experimental hypopyon model.
    Yamamoto T; Goto H; Yamakawa N; Mori H; Okada S; Fujita K; Ishikawa A
    Exp Eye Res; 2010 Nov; 91(5):685-90. PubMed ID: 20723542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental autoimmune keratitis induced in rats by anti-cornea T-cell lines.
    Verhagen C; Mor F; Kipp JB; de Vos AF; van der Gaag R; Cohen IR
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2191-8. PubMed ID: 10476783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
    Kohno H; Sakai T; Saito S; Okano K; Kitahara K
    Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.